FindMyKOL
Clinical trialNCT02869880CompletedInterventional

Trial of Enhanced Pre-Consent Discussion

NCT02869880 is an interventional trial sponsored by Children's Hospital Medical Center, Cincinnati. As of 21 Nov 2026, it is completed. It studies Pediatric Crohn's Disease. The registry lists an enrollment of 241 participants at 1 site in 1 country. The registry lists a start date of 31 Oct 2016 and a primary completion date of 31 Jul 2019.

SponsorChildren's Hospital Medical Center, CincinnatiEnrollment241Pediatric Crohn's Disease
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT02869880
FieldValue
Registry IDNCT02869880
StatusCompleted
Study typeInterventional trial
Lead sponsorChildren's Hospital Medical Center, Cincinnati
Enrollment241
Registered sites1
Countries1
ConditionsPediatric Crohn's Disease
Start31 Oct 2016
Primary completion31 Jul 2019
Study completion31 Jul 2019
Last update posted18 Jan 2020

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Nested within the COMBINE pragmatic clinical trial, the investigators will conduct a cluster randomized controlled trial to determine whether, in parents (of children with Crohn's Disease) or patients \> 18 years old being approached for trial participation, a pre-consent discussion enhanced with decision aids is more effective than the standard pre-consent discussion in transferring knowledge to parents/patients related to trial participation.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

  • Ellen Lipstein, MD, MPH

    Children's Hospital Medical Center, Cincinnati

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Ohio, United States1 site
  • Cincinnati Children's Hospital Medical Center

    Cincinnati

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhio: 1 siteOH1PennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT02869880

Each answer restates registry values shown on this page.

What is NCT02869880?

NCT02869880 is an interventional trial sponsored by Children's Hospital Medical Center, Cincinnati. It studies Pediatric Crohn's Disease.

Who leads NCT02869880?

The registry names Ellen Lipstein, MD, MPH (principal investigator, Children's Hospital Medical Center, Cincinnati) as the overall official.

Where does NCT02869880 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When did NCT02869880 end?

The registry lists a primary completion date of 31 Jul 2019 and a study completion date of 31 Jul 2019. The sponsor last updated the record on 18 Jan 2020.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.